在结直肠癌中,ALDOA和AKT表达之间的预后意义和潜在关联
Menglin Xu1, Shihang Xi2, Haoran Li3
1Department of Oncology, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241000, China.
Scientific reports
|March 19, 2024
概括
高表达的ALDOA和p-AKT表明结直肠癌 (CRC) 的预后不佳. 针对这些蛋白质可能为CRC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题,通常在晚期被诊断出来.
- 化学放射治疗等现有治疗方法面临药物耐药性挑战.
- 新的治疗目标对于改善CRC患者的治疗结果至关重要.
研究的目的:
- 调查结直肠癌组织中ALDOA和p-AKT的表达水平.
- 确定ALDOA和p-AKT表达和患者预后之间的相关性.
- 探索ALDOA和p-AKT作为CRC中的生物标志物和治疗点的潜力.
主要方法:
- 在CRC和正常组织中对ALDOA和p-AKT表达的定量分析.
- 卡普兰-梅尔生存分析以评估预后意义.
- 集群分析用于区分瘤和正常组织.
- 为预测整体存活率而构建的诺莫格拉姆.
主要成果:
- 与正常组织相比,CRC组织中的ALDOA和p-AKT表达水平显著升高.
- 高表达的ALDOA和p-AKT与不良预后和更短的生存率相关.
- 在ALDOA和p-AKT表达之间观察到正相关性.
- 集群分析有效地根据ALDOA/p-AKT表达来区分瘤与正常组织.
- 纳米图包含ALDOA/p-AKT表达,准确预测了3年和5年的整体存活率.
结论:
- 在结直肠癌中,ALDOA和p-AKT的调节显著上升,并作为预后不良的指标.
- ALDOA和p-AKT的联合表达是CRC的一个有价值的预后生物标志物.
- ALDOA/p-AKT通路调节为向的CRC疗法提供了一个有希望的途径.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.5K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.7K
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K